Sharp Edge Labs

Sharp Edge Labs

Sharp Edge Labs

Sharp Edge Labs is developing next generation biosensors based on the Fluorogen Activating Peptide technology of co-Founders Alan Waggoner and Marcel Bruchez
Founded
2011
Raised
$600k
Follow us
Alexa global traffic share
Twitter followers
30 Jun 2017
Venture capital (Series C)
19 Aug 2014
$600,000
Venture capital (Series B)